Influence of Prenatal Arsenic Exposure and Newborn Sex on Global Methylation of Cord Blood DNA by Pilsner, J. Richard et al.
Influence of Prenatal Arsenic Exposure and Newborn Sex
on Global Methylation of Cord Blood DNA
J. Richard Pilsner
1, Megan N. Hall
2, Xinhua Liu
3, Vesna Ilievski
4, Vesna Slavkovich
4, Diane Levy
3,
Pam Factor-Litvak
2, Mahammad Yunus
5, Mahfuzar Rahman
6, Joseph H. Graziano
4, Mary V. Gamble
4*
1Division of Environmental Health Sciences, School of Public Health and Health Sciences, University of Massachusetts, Amherst, Massachusetts, United States of America,
2Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York, United States of America, 3Department of Biostatistics,
Mailman School of Public Health, Columbia University, New York, New York, United States of America, 4Department of Environmental Health Sciences, Mailman School of
Public Health, Columbia University, New York, New York, United States of America, 5International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B), Dhaka,
Bangladesh, 6Columbia University Arsenic Project in Bangladesh, Dhaka, Bangladesh
Abstract
Background: An emerging body of evidence indicates that early-life arsenic (As) exposure may influence the trajectory of
health outcomes later in life. However, the mechanisms underlying these observations are unknown.
Objective: The objective of this study was to investigate the influence of prenatal As exposure on global methylation of
cord blood DNA in a study of mother/newborn pairs in Matlab, Bangladesh.
Design: Maternal and cord blood DNA were available from a convenience sample of 101 mother/newborn pairs. Measures
of As exposure included maternal urinary As (uAs), maternal blood As (mbAs) and cord blood As (cbAs). Several measures of
global DNA methylation were assessed, including the [3H]-methyl-incorporation assay and three Pyrosequencing assays:
Alu, LINE-1 and LUMA.
Results: In the total sample, increasing quartiles of maternal uAs were associated with an increase in covariate-adjusted
means of newborn global DNA methylation as measured by the [3H]-methyl-incorporation assay (quartile 1 (Q1) and Q2 vs.
Q4; p=0.06 and 0.04, respectively). Sex-specific linear regression analyses, while not reaching significance level of 0.05,
indicated that the associations between As exposures and Alu, LINE-1 and LUMA were positive among male newborns
(N=58) but negative among female newborns (N=43); tests for sex differences were borderline significant for the
association of cbAs and mbAs with Alu (p=0.05 and 0.09, respectively) and for the association between maternal uAs and
LINE-1 (p=0.07). Sex-specific correlations between maternal urinary creatinine and newborn methyl-incorporation, Alu and
LINE-1 were also evident (p,0.05).
Conclusions: These results suggest that prenatal As exposure is associated with global DNA methylation in cord blood DNA,
possibly in a sex-specific manner. Arsenic-induced epigenetic modifications in utero may potentially influence disease
outcomes later in life. Additional studies are needed to confirm these findings and to examine the persistence of DNA
methylation marks over time.
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Introduction
Naturally occurring arsenic (As) is a ubiquitous element in the
environment. Through processes that are incompletely under-
stood, As in the solid phase can become solubilized and released
into groundwater. Numerous aquifers around the world are
enriched with this metalloid, posing a tremendous public health
challenge in populations whose drinking water is obtained from
contaminated aquifers [1]. Bangladesh is one of the most severely
affected regions; approximately 35% of all tube wells contain
concentrations of As exceeding the Bangladesh drinking water
standard of 50 mg/L, and an estimated 35–77 million people are at
risk for As-induced health outcomes [2].
Arsenic is classified as a human carcinogen by the International
Agency for Research on Cancer and the U.S. Environmental
Protection Agency [3]. However, it is often referred to as a
‘paradoxical’ human carcinogen because animal models have
generally shown that As does not act as a complete carcinogen [4].
Lack of an ideal animal model due to variability in the response to
As exposure across mammalian species [5] has slowed progression
toward obtaining a complete mechanistic understanding of As-
induced health outcomes. In 2003, Waalkes et al developed a
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specific tumor formation in adulthood. Male offspring developed
liver and adrenal tumors and female offspring developed ovarian
and lung tumors [6]. Subsequent studies found aberrant gene
expression profiles and alterations in hepatic DNA methylation in
adult male mice with hepatocellular carcinoma induced by in utero
As exposure [7] and in newborn mice prior to cancer development
[8]. Emerging evidence in humans also suggests that early-life As
exposure increases the incidence of adult-onset diseases including
cancer, cardiovascular disease, and pulmonary outcomes
[9,10,11]. A study of the effects of prenatal As exposure on gene
expression profiles in newborns in Thailand reported that As
exposure activated molecular pathways indicative of stress,
inflammation, metal exposure and apoptosis [12]. Taken together,
these data suggest that there are critical developmental windows
during which As exposure increases susceptibility to adult-onset
diseases, and that these effects may be mediated through persistent
epigenetic changes.
The collective evidence supporting the role of As exposure in
the dysregulation of DNA methylation is provided in two excellent
reviews [13,14]. For example, in vitro and animal studies have
demonstrated that As exposure leads to reductions in global DNA
methylation [8,15,16,17,18,19], hypermethylation within
p16INK4a and RASSF1A promoter regions in lung tissue [20],
and hypomethylation of estrogen receptor alpha promoter in
hepatic tissue [15]. In contrast to animal studies, we previously
reported that, among Bangladeshi adults, As exposure was
positively associated with global methylation of leukocyte DNA,
and that this association was modified by plasma folate status [21].
We observed a similar relationship between As exposure and
global DNA methylation among controls within a nested case-
control study of As-induced skin-lesions [22] as have others in a
cross-sectional study from West Bengal, India [23]. Recent in vitro
studies have further indicated that As exposure can induce
alterations in post-translational modifications of histone tails
[24,25,26]. Together, the pleiotropic effects of epigenetic dysreg-
ulation represent a potential mechanism that may be common to
multiple As-induced health outcomes.
In our study of mother/newborn pairs from 101 pregnancies in
Bangladesh, we previously demonstrated strong positive correla-
tions between maternal blood As (mbAs) and cord blood As (cbAs),
indicating that As readily crosses the placenta [27]. The objective
of the present analysis was to test the hypothesis that maternal As
exposure influences global methylation of cord blood DNA.
Methods
Ethics Statement
This study was approved by the Institutional Review Board of
the Columbia University Medical Center and the Ethical Review
Committee of the ICDDR-B.
Study Participants
Between December 2004 and April 2005, pregnant women who
presented at the main hospital in Matlab, Bangladesh, were asked
by an attending physician to participate in a study designed to
characterize the As metabolic profiles among mother/newborn
pairs [27]. From this parent study, the participants in the current
study include 101 pregnant women, all of whom signed written
informed consent. This study benefited from the International
Centre for Diarrheal Disease Research-Bangladesh (icddr,b)
health and demographic surveillance system (HDSS), which
records all vital events, such as births, deaths, marriages, date of
the last menstrual period, pregnancies and pregnancy outcomes, as
well as in- and out-migration. During their pregnancies, all women
were provided with daily iron (60 mg/d) and folic acid (300 mg/d)
supplements.
Sample Collection and Storage
Near the time of delivery, women were asked to provide written
informed consent, to answer a brief questionnaire, to provide a
blood and urine sample prior to delivery, and to allow for a blood
sample to be obtained from the discarded umbilical cord after the
birth of the baby. The questionnaire was administered by a trained
nurse, who also obtained the blood and urine samples. The length,
weight and head circumference of the baby were also recorded.
Samples were collected in EDTA vacutainers and immediately
processed in the hospital laboratory. Whole blood for blood As
measurements was aliquoted into acid-washed tubes. Serum was
separated for folate, B12 and homocysteine analyses. All samples
were then frozen at 280uC. Urine samples were also collected in
acid-washed tubes and frozen at 280uC. All of the samples were
ultimately shipped to New York on dry ice and analyzed at
Columbia University.
Water As Analyses
For 100 of the 101 women, a tube well water sample was
obtained from the primary well shortly after delivery, usually
within a day, into 60-mL acid cleaned polyethylene bottles. These
were shipped to Columbia University’s Lamont Doherty Earth
Observatory where they were acidified prior to analysis. Analytical
procedures have previously been described in detail [28]. All water
samples were analyzed using an axiom single-collector high-
resolution inductively-coupled plasma mass spectrometer (HR
ICP-MS) (Thermo elemental, Erlanger, Germany). The analytical
detection limit of the method is 0.1 mg As/L; the standard
deviation of a single measurement is conservatively estimated at
4 mg/L for concentrations up to 150 mg/L and 2% for samples .
150 mg/L [29].
Total Urinary and Blood As Measurements
Urinary As (uAs) concentrations were assayed by graphite
furnace atomic absorption spectrophotometry (GFAA) using a
Perkin-Elmer AAnalyst 600 system (Shelton, CT) as described
[30]. Our laboratory participates in a quality control program
coordinated by the Quebec Toxicology Center in Quebec,
Canada. During the course of this study, intraclass correlation
coefficients between our laboratory’s values and samples calibrated
at the Quebec Toxicology Center were 0.99. The detection limit
of the method is 2 mg/L. In order to correct for urine dilution, we
also measured urinary creatinine (uCrn) concentrations using a
standard colorimetric method based on Jaffe’s reaction [31] with
reagents from Sigma Diagnostics (Sigma, St. Louis, MO).
Maternal and cord blood samples were analyzed for total blood
As concentration using a Perkin-Elmer Elan DRC II ICP-MS
equipped with an AS 93+ autosampler as described [27]. Briefly,
the As concentration of the standard solution used for instrument
calibration was chosen to cover the expected range of As
concentrations in the blood samples: 5, 25 and 50 mg/L. Matrix
suppression was compensated for by the use of iridium (Ir) as an
internal standard, selected to match to the ionization potential of
As. Spectral interferences for As were resolved with Dynamic
Reaction Cell (DRC) technology by introducing oxygen as a
second gas. The intraclass correlation coefficients between our
laboratory’s values and samples calibrated at the Quebec
Toxicology Center were 0.99. The detection limit of the method
is 0.06 mg/L.
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Genomic DNA was isolated at Columbia University from
300 ml of frozen whole blood samples using the FlexiGene DNA
kit (Qiagen) following the manufacturer’s protocol, except for an
additional centrifugation step at 10,0006g for 5 min immediately
after protease digestion to pellet any remaining proteins or lipids.
The supernatant was then transferred into a new microcentrifuge
tube containing 150 ml of isopropanol. The remainder of the
procedures were conducted according to the manufacture’s
protocol. All extractions yielded $2 mg of DNA with a 260/280
ratio $1.7.
Global DNA methylation
Methyl Incorporation Assay. The methyl-incorporation
assay was performed by the method of Balaghi and Wagner [32]
as we have previously described in detail [21,33]. DNA was
incubated with [
3H]-SAM in the presence of the SssI prokaryotic
methylase enzyme, which indiscriminately methylates all un-
methylated cytosines in CpG sequences. The ability of DNA to
incorporate [
3H] methyl groups in vitro is inversely related to
endogenous DNA methylation. Briefly, 250 ng of DNA was
incubated for 1 hr at 37uC with 3 U of SssI methylase (New
England Biolabs, Beverly, MA), 3.8 uM (1.1 mCi)
3H labeled SAM
(GE Healthcare), and EDTA, DTT and Tris-HCL (pH 8.2). The
reaction mixtures were applied onto Whatman DE81 filter papers
and washed on a vacuum filtration apparatus and air dried. Dried
filters were analyzed by a Packard Tri-Carb 2100TR Liquid
Scintillation Analyzer. Each DNA sample was processed in
duplicate and each processing run included samples for back-
ground (reaction mixture with all components except SssI
enzyme), a hypomethylation control (HeLa cell DNA) and a
quality control sample (DNA extracted from a whole-blood
sample). The intra- and inter-day coefficients of variation (CVs)
were 1.8% and 5.3%, respectively. To quantify the amount of
double-stranded input DNA in each reaction, an aliquot of the
assayed DNA was used to determine DNA concentrations using
PicoGreen dsDNA Quantitation Reagent (Molecular Probes). All
disintegrations per minute (DPM) values were expressed per mg
DNA.
Alu and LINE-1 methylation. DNA samples (500 ng at
20 ng/ml) were bisulfite-treated using the EZ-96 DNA Methyla-
tion-Gold Kit
TM (Zymo Research, Orange, CA). Bisulfite conver-
sion of DNA changes unmethylated cytosine to uracil and
subsequently to thymidine after PCR whereas methylated
cytosines are protected from bisulfite conversion, resulting in
methylation-dependent differences in DNA sequences. Bisulfite-
converted DNA was stored at 220uC until further use. LINE-1
and Alu methylation was measured by quantitative Pyrosequenc-
ing (Qiagen) using primers and conditions as described previously
[34,35]. Pyrosequencing employs a primer extension reaction,
using a biotin-labeled single stranded PCR amplicon as template,
in which pyrophosphatase (PPi) is released during the incorpora-
tion of each nucleotide in equimolar proportion to that
incorporated. The level of methylation for each CpG target
region was quantified using the Pyro Q-CpG Software. Human
whole-genome amplified DNA and a methylated standard (Zymo
Research, Orange CA) were used as 0% and 100% methylated
controls, respectively. Inter-day CVs for Alu and LINE-1 were
2.0% and 0.8%, respectively.
LUMA. The Luminometric Methylation Assay (LUMA) has
been described in detail elsewhere [36,37]. LUMA is based on
recognition and cleavage of 59- CCGG -39 sequences by the
methylation sensitive restriction enzyme (HpaII) and its methyl-
ation insensitive isoschizomer (MspI) in parallel reactions. Addi-
tionally, EcoRI is included in all reactions to normalize the
amount of DNA input. The extent of restriction cleavage is then
measured by bioluminometic polymerase extension via Pyrose-
quencing.
Briefly, genomic DNA (300 ng) was digested with HpaII+EcoRI
and MspI+EcoRI in parallel reactions containing 2 ml of Tango
buffer (Fermentas, Glen Burnie, MD), 5 U of HpaII or MspI, 5 U
of EcoRI and dH2O to a final volume of 20 ml. Samples were
incubated at 37uC for 4 hours. After the incubation, 15 mlo f
Pyrosequencing annealing buffer was added to samples. After
mixing, 30 ml of the sample reaction containing the annealing
buffer was transferred to 96 well Pyrosequencing plates and run
with the following nucleotide dispensation order: GTGTCA-
CATGTGTG [36,38]. Peak heights of nucleotide incorporation
from the resulting pyrograms were used to calculate % global
DNA methylation using the formula: 12[(HpaII(G)/EcoRI(T))/
(MspI(G)/EcoRI(T))]6100, where G and T are the peak heights
for HpaII or MspI (methylation) and EcoRI (input DNA),
respectively. All samples were run in duplicate. The intra- and
inter-day CVs were 0.55% and 3.01%, respectively.
Plasma Folate, Cobalamin and Homocysteine
Plasma folate and total cobalamin from maternal and cord
blood were analyzed by radioimmunoassay (Quantaphase II, Bio-
Rad Laboratories, Richmond CA) as described previously [39].
The intra- and inter-day CVs for folate were 3% and 11%,
respectively, and those for cobalamin were 4% and 8%,
respectively. Plasma tHcys concentrations were measured by
HPLC with fluorescence detection according to the method
described by Pfeiffer et al [40]. The intra- and inter-day CVs for
tHcys were 5% and 8%, respectively.
Statistical Analyses
Descriptive statistics were calculated for sample characteristics
of mothers and their newborns and by newborns’ sex. Sex
differences for continuous variables were assessed using the
Wilcoxon rank-sum test. Pyrosequencing data that did not pass
Pyro Q-CpG Software quality scores or were not reproducible
were excluded from analyses; these included three samples (one
maternal Alu, one newborn Alu and one newborn LINE-1). For
the methyl-incorporation assay, quality data was available for 98
samples. Spearman correlation coefficients were used to assess
bivariate associations between maternal and newborn DNA
methylation and sex specific correlations between uCrn and
DNA methylation measures. Wald tests were used to evaluate
differences in correlations by sex. Linear regression models were
used to examine associations between As exposures and DNA
methylation measures controlling for uCrn, including a uCrn by
sex interaction term as appropriate. An As by sex interaction term
was added to test for sex differences in the effect of As on DNA
methylation. We also categorized uAs adjusted for uCrn, defined
as the residual from regressing log uAs on sex-specific log uCrn,
into quartiles, and computed mean levels of global DNA
methylation for each quartile. All analyses were performed using
SAS (version 9.2; SAS Institute Inc., Cary, NC).
Results
The demographic and clinical data of the study population are
presented in Table 1. The mean age of the women was 26.765.3
years and mean parity was 1.860.9. Of the 101 births, 58 were
males. The average birth weight was higher among male
compared to female newborns (2,830.56517.2 g vs
2,647.06336.5 g; p,0.05). Gestational age did not differ between
Prenatal Arsenic and Newborn DNA Methylation
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0.01 to 661 mg/L; 28% and 38% of tube wells exceeded the
Bangladesh standard of 50 mg/L and the World Health Organi-
zation guideline of 10 mg/L, respectively. As previously reported
[27], there was a strong correlation between cbAs and mbAs
concentrations (r=0.84; p,0.0001), with the mean cbAs concen-
tration higher than the mean mbAs concentration (15.7 mg/L vs.
11.9 mg/L, respectively; p,0.0001). There were no significant
differences in As exposures by newborn sex. As compared to male
newborns, female newborns had higher maternal plasma homo-
cysteine (6.761.5 mmol/L vs. 6.161.6 mmol/L; p=0.04) and
cord plasma homocysteine (6.161.4 mmol/L vs. 5.461.3 mmol/L;
p=0.008). None of the As exposure variables were significantly
associated with gestational age, birth weight and length, or head
circumference; however, male newborns had higher placenta and
birth weight and larger head circumference as compared to female
newborns (p,0.05).
Global DNA methylation levels for the methyl-incorporation,
Alu, LINE-1 and LUMA assays for mothers and newborns are
also provided in Table 1 (full methylation data are available on
request for academic or non-commercial purposes). Data are
expressed as the percent of DNA methylation for Alu, Line-1 and
LUMA. For the methyl-incorporation assay, the data are
expressed as disintegrations per minute per microgram DNA
(DPM/mg DNA), and are inversely related to endogenous DNA
methylation levels. LINE-1 methylation was higher in male
compared to female newborns (79.5861.8 vs. 78.8261.4;
p=0.001). The associations between mother/newborn pairs for
each DNA methylation assay are shown in Table 2. Positive
associations between mother/newborn pairs were observed for
DNA methylation as measured by methyl-incorporation (Spear-
man correlation coefficient: r=0.32, p=0.001), LUMA (r=0.22,
p=0.03), and LINE-1 (r=0.21, p=0.03). The correlation
between mother/newborn pairs for Alu methylation was not
statistically significant. In newborn sex-specific analyses, the
associations between mother/newborn pairs for the methyl-
incorporation assay were similar among male (r=0.35,
p=0.007) and female (r=0.31, p=0.047) newborns. For the
three pyrosequencing assays; however, the associations between
maternal/newborn DNA methylation levels differed by newborn
sex. For example, the correlations between mother/newborn pairs
were significant for Alu methylation and LUMA among female
newborns (r=0.42, p=0.005 and r=0.37, p=0.02, respectively),
but not among male newborns. In contrast, a significant
correlation for LINE-1 methylation was apparent only among
male newborns (r=0.39, p=0.002).
No significant correlations were observed between As exposure
and maternal and newborn DNA methylation (Table S1).
However, in linear regression models adjusting for sex-specific
effects of maternal uCrn levels, maternal uAs was negatively
related with newborn methyl-incorporation levels (Table 3:
b=2204961087; p=0.06). Figure 1 shows the pattern of the
mean level of newborn DNA methylation, measured by the
methyl-incorporation assay, among quartiles of maternal uAs
adjusted for the sex-specific effect of uCrn. The mean newborn
methyl-incorporation levels tended to decrease with increasing
maternal uAs, indicating that uAs is associated with an increase in
global DNA methylation. Compared to the first and second lowest
quartiles of maternal uAs, newborns in the highest quartile of
maternal uAs had lower methyl incorporation levels (Q1:
91,33162,499 DPM/mg DNA and Q2: 92,02162,436 DPM/mg
DNA vs. Q4: 84,74562,491 DPM/mg DNA (p=0.06 and 0.04,
respectively). Maternal uAs was not significantly associated with
newborn methylation of Alu, LINE-1 and LUMA in the total
sample (Table 3). We also found no significant associations
between mbAs or cbAs concentrations and measures of newborn
DNA methylation in the total sample.
In secondary analyses, we observed sex-specific patterns of
association between As exposure and newborn DNA methylation
via pyrosequencing (Table 3). Arsenic exposure measurements,
while not statistically significant, were negatively related to the
DNA methylation measures, Alu, LINE-1, and LUMA, for female
newborns (N=43), whereas these relationships were positive for
male newborns (N=58). Moreover, we observed borderline
significant sex differences in the associations between blood As
levels, cbAs and mbAs, and Alu methylation (p=0.05 and 0.09,
respectively) and between maternal uAs and LINE-1 methylation
(p=0.07). The methyl-incorporation assay did not display a sex-
specific pattern of association with As exposure.
While not part of our a priori hypothesis, we observed an
unexpected relationship between maternal uCrn levels and
newborn global DNA methylation dependent on newborn sex
(Table 4). Among male newborns, maternal uCrn was positively
correlated with global DNA methylation (methyl-incorporation:
r=20.12, p=0.38; Alu: r=0.34, p,0.01 and LINE-1: r=0.28,
p,0.05). In contrast, among female newborns, maternal uCrn was
negatively related with DNA methylation (methyl-incorporation:
r=0.49, p,0.01; Alu: r=20.06, p=0.69; and LINE-1:
r=20.14, p=0.36). We also found that these sex-specific patterns
of association between maternal uCrn and newborn DNA
methylation measures, i.e.methyl-incorporation, Alu and LINE-1
methylation, were statistically different (p,0.05). The sex differ-
ence in the associations of uCrn with methyl-incorporation and
LINE-1 methylation were still evident in linear regression models
when uAs was included in the model (p=0.002 and =0.07,
respectively). A similar sex-specific pattern of association was
evident between cord blood homocysteine and newborn DNA
methylation measures, although only LINE-1 methylation reached
statistical significance (p,0.05). Sex-specific patterns were not
evident between other indicators of one-carbon metabolism and
newborn DNA methylation.
Discussion
The objective of this study was to investigate the associations
between prenatal As exposure and global methylation of cord
blood DNA. In the total sample, our data indicated that maternal
uAs was positively related to global methylation of cord blood
DNA as assessed by the methyl-incorporation assay. In secondary
analyses, we observed sex-specific patterns of association between
As exposure and DNA methylation. Among male newborns, there
was a consistent positive association between As exposure and
DNA methylation. In contrast, As exposure was generally
inversely associated with DNA methylation among female
newborns. To our knowledge, there are no previous mother/
newborn studies in humans investigating the association between
prenatal As exposure and global methylation of cord blood DNA.
Growing evidence in human and animal studies suggests that
early-life exposure to As increases the incidence of adverse health
outcomes later in life, despite a reduction or elimination of
exposure during adulthood. For example, inhabitants of Chile’s
region II who were born just prior to or during an acute increase
in water As concentrations, resulting in early-life and prenatal
exposure, had higher mortality rates from malignant and
nonmalignant lung disease and acute myocardial infarction as
young adults compared to unexposed individuals from a different
region [9,10,11]. The data also indicated that sex modified the
effects of early-life As exposure and subsequent mortality rates,
Prenatal Arsenic and Newborn DNA Methylation
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Mother
a Newborn
a
Variable (N=101) Male (N=58) Female (N=43)
Maternal
Age (years) 26.7 (5.3) 27.5 (5.4) 25.7 (5.0)
Education (years) 7.4 (3.6) 7.6 (3.5) 7.2 (3.7)
Parity 1.8 (0.90) 1.9 (0.8) 1.7 (0.9)
Water arsenic (mg/L) 90.5 (165.8)
b 92.5 (157.0) 87.8 (179.2)
h
Urinary arsenic (mg/L) 127.6 (232.9) 134.3 (226.1) 118.7 (244.3)
Urinary creatinine (mg/dl) 48.6 (35.3) 47.6 (32.9) 50.1 (38.7)
Urinary arsenic (ug/g creatinine) 271.7 (489.5) 282.1 (450.3) 257.7 (543.1)
Blood arsenic (mg/L) 11.9 (8.6) 12.6 (10.1) 10.9 (6.0)
Plasma folate (nmol/L) 20.3 (9.9)
c 20.7 (79.6) 19.6 (9.4)
i
Plasma homocysteine (mmol/L) 6.4 (1.5) 6.1 (1.6) 6.7 (1.5)*
Plasma B12 (pmol/L) 180.8 (71.5)
d 193.6 (79.6) 163.2 (54.9)
j
Newborn
Gestational age (days) 275.9 (18.1) 281.7 (13.9)
Placenta weight (g) 531.4 (127.9) 489.5 (106.4)*
Birth weight (g) 2830.5 (517.2) 2647.0 (336.5)*
Head circumference (cm) 32.1 (3.0)
e 31.2 (1.4)*
Birth length (cm) 48.2 (3.5) 47.7 (1.9)
j
Cord plasma folate 52.4 (17.8)
g 53.2 (15.3)
h
Cord plasma homocysteine (mmol/L) 5.4 (1.3)
e 6.1 (1.4)**
Cord plasma B12 (pmol/L) 409.4 (255)
g 313.4 (150.0)
k
Cord blood As (mg/L) 16.0 (9.9) 15.3 (6.9)
DNA methylation
Methyl-incorporation (DPM/ug DNA) 91,718 (15,300) 89,024 (12,171)
f 89,915 (13,861)
h
Alu (%) 24.70 (0.81)
b 24.76 (1.2)
e 24.69 (1.0)
LINE-1 (%) 79.12 (1.38) 79.58 (1.8) 78.82 (1.4)
h**
LUMA (%) 74.72 (2.48) 74.88 (2.6) 74.86 (3.7)
aValues are mean (SD).
bN=100,
cN=99,
dN=95,
eN=57,
fN=56,
gN=54,
hN=42,
iN=41,
jN=40,
kN=37.
*P,0.05; Wilcoxon rank sum test for differences between newborn sex.
**P,0.01; Wilcoxon rank sum test for differences between newborn sex.
doi:10.1371/journal.pone.0037147.t001
Table 2. Spearman correlation coefficients for global DNA methylation between maternal vs. newborn pairs, combined and
stratified by newborn sex.
Methyl-incorporation Alu LINE-1 LUMA
r( n ) r( n ) r( n ) r( n )
Total Sample 0.32 (98)
** 0.15 (99) 0.21 (100)
* 0.22 (101)
*
Male newborns 0.35 (56)
** 20.05 (57) 0.39 (58)
** 0.12 (58)
Female newborns 0.31 (42)
* 0.42 (42)
** 20.02 (42) 0.37 (43)
*
*p,0.05;
**p,0.01.
doi:10.1371/journal.pone.0037147.t002
Prenatal Arsenic and Newborn DNA Methylation
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DPM/mg DNA Alu LINE-1 LUMA
b ± se (p-value) b ± se (p-value) b ± se (p-value) b ± se (p-value)
Total Sample
1
Water As 2196.16412 (0.64) 20.000460.04 (0.99) 20.01660.05 (0.76) 20.12660.10 (0.21)
mbAs 21858.262478 (0.46) 20.03560.22 (0.87) 0.18960.32 (0.55) 0.26760.60 (0.66)
cbAs 21627.362417 (0.50) 20.04660.21 (0.83) 0.20160.32 (0.53) 0.06060.60 (0.92)
uAs 22049.261087 (0.06) 20.00360.10 (0.98) 20.02260.14 (0.87) 0.00960.27 (0.71)
Female cord blood
Water As 334.96668 (0.62) 20.037860.05 (0.45) 20.05060.07 (0.50) 20.31160.19 (0.12)
mbAs 22902.563834 (0.45) 20.46460.29 (0.12) 20.26660.43 (0.54) 20.53061.12 (0.64)
cbAs 22037.163507 (0.56) 20.45860.27 (0.09) 20.05360.41 (0.90) 20.44561.02 (0.66)
uAs 21771.161657 (0.29) 20.16460.13 (0.21) 20.31460.18 (0.09) 20.21860.49 (0.66)
Male cord blood
Water As 2416.06526 (0.43) 0.03560.05 (0.48) 0.04760.07 (0.53) 0.00560.12 (0.97)
mbAs 21063.563274 (0.75) 0.28360.30 (0.35) 0.51560.45 (0.25) 0.82760.68 (0.23)
cbAs 21227.7+3379 (0.72) 0.35560.31 (0.26) 0.43060.47 (0.36) 0.55360.71 (0.44)
uAs 22279.061454 (0.13) 0.12360.14 (0.37) 0.19660.20 (0.33) 0.33060.30 (0.28)
Total sample
1,2
Water As x sex 2871.36842 (0.30) 0.03960.07 (0.60) 0.08560.11 (0.44) 0.28960.20 (0.16)
mbAs x sex 1839.065026 (0.72) 0.74760.43 (0.09) 0.78160.64 (0.23) 1.42661.22 (0.25)
cbAs x sex 809.564860 (0.87) 0.81360.42 (0.05) 0.48260.63 (0.45) 1.03261.20 (0.39)
uAs x sex 2507.962195 (0.82) 0.28860.19 (0.14) 0.51060.28 (0.07) 0.55360.47 (0.24)
1Sex- specific effect of uCrn was controlled in the models for DPM/DNA, Alu and Line-1.
2Interaction by newborn sex.
doi:10.1371/journal.pone.0037147.t003
Figure 1. Newborn global DNA methylation and maternal urinary As exposure. Mean (SE) newborn global methylation levels as measured
by the methyl-incorporation assay by quartiles of maternal uAs exposure adjusted for the sex-specific effect of uCrn. * Q1 and Q2 vs. Q4; p=0.06 and
0.04, respectively.
doi:10.1371/journal.pone.0037147.g001
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acute myocardial infarction than females. Likewise, animal models
have shown that brief prenatal exposure produced tumor
formation in adulthood in a sex-specific manner [6]. Interestingly,
tumor-free newborn mice, subjected to the same prenatal exposure
protocol, exhibited similar changes in hepatic gene expression as
observed in adult mice with hepatic tumors as well as reduced
hepatic DNA methylation within GC-rich regions [8]. These
studies indicates that epigenetic processes mediate persistent
changes in gene expression and that newborn sex modifies the
incidence of adult-onset diseases in response to early-life As
exposure. Our data is consistent with the possibility that sex-
specific epigenetic effects of As exposure could induce differential
health outcomes between males and females later in life.
Overall, our results indicate that maternal uAs is positively
associated with newborn global DNA methylation as assessed by
the methyl-incorporation assay. Previous studies from our group
have demonstrated that uAs concentrations were associated with
an increase in global DNA methylation among Bangladeshi adults
[21,22]. Similarly, As-associated increases in global DNA meth-
ylation were found among adults from West Bengal, India [23].
While animal and cell culture experiments have shown that As
exposure is associated with global DNA hypomethylation
[8,15,16,17,18,19], our contradictory findings may be a result of
differences in tissues/cells analyzed and duration and/or magni-
tude of exposure [21].
Our previous studies also found that plasma folate modified the
association between As exposure and global DNA methylation,
such that only participates with adequate folate status ($9 nmol/
L) showed a positive association [21,22]. In the current study, most
of the women in the study were taking prenatal vitamin
supplements; therefore, plasma concentrations of folate and B12
are reflective of recent supplement use rather than long-term
nutritional status. While B12 was found to be inversely correlated
with LINE-1 methylation, we consider the direction of the
correlation to be opposite to what one might have predicted and
may have been a chance observation. Adjusting for folate and
other covariates did not influence the magnitude of this effect (data
not shown).
In secondary analyses, we found that newborn sex modified the
association between As exposure and global methylation of cord
blood DNA. Although the associations did not reach statistical
significance, arsenic exposure and DNA methylation were
positively associated in males and inversely associated in females.
Table 4. Spearman correlation coefficients for newborn global DNA methylation vs. urinary creatinine and indicators of one-
carbon metabolism in plasma, combined and stratified by newborn sex.
Methyl-incorporation Alu LINE-1 LUMA
r( n ) r( n ) r( n ) r( n )
Total Sample
Maternal urinary creatinine 20.16 (98) 0.16 (100) 0.14 (100) 20.16 (101)
Maternal folate 0.06 (96) 20.04 (98) 20.11 (98) 0.08 (99)
Maternal B12 20.05 (92) 20.09 (94) 20.03 (94) 0.05 (95)
Maternal homocysteine 0.06 (98) 0.06 (100) 20.01 (100) 0.07 (101)
Cord folate 0.03 (93) 20.18 (95) 20.16 (95) 0.02 (96)
Cord B12 0.02 (89) 20.09 (90) 20.23 (90)* 20.003 (91)
Cord homocysteine 0 (97) 0.03 (99) 20.07 (99) 20.05 (100)
Male newborns
Maternal urinary creatinine 20.12 (56) 0.34 (57)** 0.28 (58)* 20.12 (58)
Maternal folate 0.23 (56) 20.10 (57) 20.19 (58) 0.11 (58)
Maternal B12 20.02 (53) 20.20 (54) 20.19 (55) 20.11 (55)
Maternal homocysteine 20.04 (56) 0.10 (57) 0.08 (58) 0.14 (58)
Cord folate 0.09 (52) 20.31 (53)* 20.25 (54) 0.03 (54)
Cord B12 0.08 (53) 20.21 (53) 20.32 (54)* 20.10 (54)
Cord homocysteine 20.08 (55) 0.12 (56) 0.14 (57) 0.03 (57)
Female newborns
Maternal urinary creatinine 0.49 (42)**
,b 20.06 (43)
a 20.14 (42)
a 20.15 (43)
Maternal folate 20.17 (40) 0.02 (41) 0.01 (40) 0.10 (41)
Maternal B12 20.04 (39) 0.05 (40) 0.12 (39) 0.32 (40)*
Maternal homocysteine 0.14 (42) 0.04 (42) 20.04 (42) 20.07 (43)
Cord folate 20.08 (41) 20.01 (42) 0.01 (41) 0.01 (42)
Cord B12 20.03 (36) 0.10 (37) 20.27 (36) 0.20 (37)
Cord homocysteine 0.07 (42) 20.12 (43) 20.27 (42)
a 20.28 (43)
*p,0.05;
**p,0.01.
ap,0.05;
bp,0.01 from Wald test for sex differences in correlations.
doi:10.1371/journal.pone.0037147.t004
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hypothesis. However, a growing body of evidence in humans
suggests that sex differences may arise in epigenetic responses to
prenatal environmental exposures [41]. For example, the Dutch
Hunger Winter Families Study found prenatal exposure to famine
was associated with sex-specific DNA methylation changes that
persisted into adulthood [42]. It has been proposed that sex-
specific epigenetic differences may be due to sex hormones and
their effects on organ development [41]. Although limited data
exists on hormonal regulation of epigenetic processes during the
neonatal period, progesterone and estrogen have been shown to
downregulate DNA methyltransferase expression in women [43],
and higher methylation of repetitive sequences has been reported
in adult men as compared to women [44,45]. We also observed
that male newborns had significantly higher LINE-1 methylation
in cord blood as compared to female newborns. Interestingly, a
recent study in adult mice reported sex-specific changes in hepatic
global DNA methylation. In response to As exposure and a
methyl-deficient diet, female mice had a significant increase in
DNA methylation whereas male mice had a decrease in DNA
methylation [46].
Our findings for sex-specific associations between maternal
uCrn and global DNA methylation in cord blood were unantic-
ipated. Numerous studies from our group have showed that uCrn
is a strong predictor of As methylation [27,47,48,49]. Moreover,
uCrn was found to be an independent predictor of the risk for
development of As-induced skin lesions, such that every doubling
of uCrn concentrations was associated with 60% reduced risk for
skin lesion development [22]. The final step in creatine
biosynthesis is a methylation reaction which consumes roughly
50% of all SAM [50,51], and endogenous creatine synthesis is
downregulated by dietary creatine intake. Creatine, together with
several isoforms of creatine kinase, plays critical roles in many
aspects of energy metabolism in tissues with high energy
requirements [52]. Because creatine is nonenzymatically degraded
to creatinine, which is excreted in urine at a constant rate, uCrn is
commonly used to normalize for fluctuations in the concentration
of urine. However, uCrn concentrations are strongly influenced by
other factors such as dietary creatine intake from protein sources,
age, sex, and muscle mass [53,54]. Although little is known about
fetal requirements for creatine, animal studies indicate that the
creatine transporter, responsible for cellular creatine uptake, is
widely expressed very early in development, whereas fetal creatine
biosynthesis doesn’t occur until very late in pregnancy, suggesting
that the developing fetus is dependent on transport of maternal
creatine across the placenta [55]. It is unclear why we observed
sex-specific patterns of association (e.g., positive in male and
negative in female newborns) between DNA methylation and
maternal uCrn levels. Creatine biosynthesis is differentially
influenced by estrogen and testosterone [52], and maternal
circulating sex hormone concentrations are influenced by the sex
of the fetus [56]. Thus, although speculative, it is possible that
maternal creatine biosynthesis is influenced by fetal hormone
levels. Because estrogen levels may be associated with both
creatinine and DNA methylation, it is possible that the sex-specific
association between maternal uCrn and cbDNA methylation
could be explained by estrogen. However, we cannot rule out the
possibility that this was simply a chance observation, and
additional studies are needed to replicate this unexpected finding.
An advantage of this study is the use of multiple assays to
estimate global DNA methylation levels. Although the four
methods have been used widely as indicators of global DNA
methylation [32,38,57], the genomic targets for each assay are
distinct. They can be classified as either genome-wide assays
(methyl-incorporation and LUMA) or as repetitive element assays
(Alu and LINE-1). Of the four assays, the methyl-incorporation
assay provides the greatest genomic coverage, as it measures all
unmethylated CpG sites across the genome. Of note, this reaction
(using unlabeled S-adenosylmethionine) is routinely used to
generate 100% methylated DNA standards for other DNA
methylation techniques, such as Pyrosequencing [58]. Using the
methyl-incorporation assay, DNA methylation was positively
associated with maternal uAs levels in our total study sample
and also showed the strongest correlation between mother and
newborn DNA methylation levels. LUMA is another genome-wide
assay that employs the methyl-sensitive and insensitive enzymes,
HpaII and MspI, respectively, to interrogate the methylation
status of the estimated 2.2 million CpG dinucleotides contained
within CCGG sequences in the human genome [59]. LUMA has
been previously shown to be associated with environmental
exposures [36]. However, only roughly 8% of total genomic
CpGs are located within CCGG HpaII recognition sequence [59],
thus the leaner coverage may explain why our results for LUMA
were not as robust as our findings for the methyl incorporation
assay.
Alu and LINE-1 are highly repetitive elements. Approximately
1.5 million copies of Alu and 0.5 million copies of LINE-1 are
dispersed throughout the genome. Together they comprise around
25% of the genome and . 40% of methylated CpG domains
[34,60]. As such, Alu and LINE-1 methylation are considered to
be surrogates for global DNA methylation and have been found to
be associated with a number of environmental exposures
[35,61,62]. These methylation analyses are based on PCR
amplification of consensus LINE-1 and Alu sequences, which
amplifies a representative subset of elements (e.g. approximately
1% of Alu elements [57]). Downstream sequencing is then limited
to three (Alu) and four (LINE-1) consecutive CpG dinucleotides.
In our study, Alu and LINE-1 methylation display a distinct sex
difference in association with As exposure. It is unclear if these
differential associations are influenced by sex hormones of the
developing fetus or other unidentified factors.
An unanticipated finding was that the associations between
maternal DNA methylation and that of her newborn as measured
by Pyrosequencing differed by newborn sex, such that LINE-1
methylation was correlated only among male newborn/maternal
pairs, whereas Alu methylation was correlated among female
newborn/maternal pairs. These inconsistencies complicate the
interpretation of Alu and LINE-1 as surrogates for global DNA
methylation. A potential explanation for these differences may be
related to the fact that Alu and LINE-1 use different types of
internal RNA polymerase promoters, suggesting that these
repetitive elements may be under different selective pressures
[63]. Differences in copy numbers within sex chromosomes may
also contribute to these inconsistencies. It has also been reported
that higher annealing temperatures produced larger differences in
LINE-1 methylation levels between sexes [45].
A limitation to this study is our use of a convenience sample of
participants drawn from a study that was originally designed to
characterize the As metabolite profiles among only 101 mother/
newborn pairs [27]. This resulted in low statistical power for the
current study, especially after stratifying our data by sex or testing
for interactions. Although this impaired our ability to detect
statistically significant associations, the data are strongly suggestive
of an influence of maternal As exposure on cord blood DNA
methylation that may differ by sex.
In conclusion, the results of this study suggest that newborn sex
may modify the association between prenatal As exposure and
global methylation of cord blood DNA. Our data offer a plausible
Prenatal Arsenic and Newborn DNA Methylation
PLoS ONE | www.plosone.org 8 May 2012 | Volume 7 | Issue 5 | e37147epigenetic mechanism by which prenatal As exposure may
contribute to observed sex differences in As-induced health
outcomes later in life. Additional studies are needed to confirm
these results and to examine the persistence of DNA methylation
marks across the lifecourse.
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